Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Status unconfirmed · Not applicable

Conditions studied: Tardive Dyskinesia

In brief

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

Key facts

Study ID

NCT06011408

Run by

iRxReminder

People needed

300

Starts

2023-05-30

Expected to finish

2024-12-31

Last updated by the study team

2024-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• For the non-TD group:
• Prescribed and taking an antipsychotic medication for 90-days or longer.
• Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
• Signed an informed consent.
• Speaks English fluently.

You may not qualify if…

• Suffered a moderate or severe head injury in the last year;
• History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
• Severe visual impairment that is cannot be corrected by glasses or contacts.

Where it is running

• Fermata Helath — Brooklyn, New York, United States (enrolling)
• Charak Research Center — Garfield Heights, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.